Schedule 13D ownership disclosure
Benitec Biopharma Inc
Security class unavailable · CUSIP: 08205P209
Event date: 2024-09-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,883,385
- Percent of class
- 44.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-24-001043
- Form type
- SC 13D
- Filer
- Benitec Biopharma Inc.
- CIK
- CIK 1808898
- Filed
- Sep 30, 2024
- Reporting period
- Sep 26, 2024
- Description
- Schedule 13D beneficial ownership